influence on their biological activity.7 In this respect, a classical
example is compound (R)-(+)-Bay K 8644, which shows anti-
hypertensive activity due to its calcium antagonist effect,
whereas the S enantiomer induces the opposite response (Figure
1).
derived organocopper reagents15 have been used in diastereo-
selective additions to the 4-position of pyridines. To date, only
three examples of catalytic enantioselective syntheses of 1,4-
DHPs have been described, both in an organocatalytic fashion.16
Chiral sulfoxides are reliable chiral synthons able to bring
about important asymmetric transformations.17 In this context,
metalated allylic sulfoxides, despite the ambident reactivity of
the carbanion, have been used as chiral inducers in their addition
to conjugated enones.18 The reaction takes place almost
exclusively through the γ-position giving rise to the corre-
sponding vinyl sulfoxidessa successfully applied strategy for
the synthesis of natural products.19 As part of our continued
interest in the preparation of new fluorinated building blocks,20
and taking advantage of the enhanced electrophilicity of
fluorinated nitriles, we envisioned the possibility of using them
as reaction partners with metalated allyl sulfoxides. The attack
by the γ-position would provide enamino sulfoxides, which in
turn could be treated with alkyl propiolates to afford fluorinated
1,4-DHPs. Herein, we report the development of this closely
related asymmetric Hantzsch transformation by using allylic
sulfoxides, fluorinated nitriles, and alkyl propiolates as the three
components of the novel one-pot tandem reaction outlined in
Scheme 1. This methodology allows for the preparation of a
new family of enantiomerically pure fluorinated 1,4-DHPs.21
Figure 1. Influence of the chiral center on the biological activity of
DHPs.
Despite the biological importance of enantiomerically pure
DHPs, a general method for their asymmetric synthesis still
remains an important challenge. Traditional strategies make use
of either enzymatic8 or chemical9 resolutions of racemates or,
alternatively, chiral auxiliaries. In this context, sugar-derived
aldehydes,10 chiral acetoacetate esters,11 chiral amino alde-
hydes12 (derived from the corresponding R-amino acids), and
chiral sulfoxides13 have been reported as asymmetry inducers
for the synthesis of 1,4-DHPs in Hantzsch syntheses. Alterna-
tively, chiral oxazoline-derived aryl lithiums14 and chiral aminal-
Our synthetic strategy starts with the reaction of allyl
sulfoxide 1 through the γ-position with fluorinated nitriles 2 to
generate enamino sulfoxides 4. Upon treatment with alkyl
propiolates 3, a tandem intermolecular aza-Michael reaction
(AMR)-intramolecular Michael addition (IMA) (over the
previously formed vinyl sulfoxides 5)22 might render 1,4-DHPs
6 (Scheme 1).
We initially explored the preparation of enamino sulfoxides
4 to evaluate our synthetic proposal. After testing several bases
and temperatures, we found that optimal reaction conditions
involved the treatment of (R)-(+)-allyl p-tolyl sulfoxide 1 with
KN(SiMe3)2 at -78 °C, followed by addition of fluorinated
nitriles 2. The reaction took place exclusively over the γ-carbon
(6) For reviews of related multicomponent reactions, see: (a) Dondoni, A.;
Massi, A. Acc. Chem. Res. 2006, 39, 451. (b) Lie´by-Muller, F.; Simon, C.;
Constantieux, T.; Rodriguez, J. QSAR Combi. Sci. 2006, 25, 432. (c) Simon,
C.; Constantieux, T.; Rodriguez, J. Eur. J. Org. Chem. 2004, 4957.
(7) (a) Shan, R.; Howlett, S. E.; Knaus, E. E. J. Med. Chem. 2002, 45,
ˇ
955. (b) Marchal´ın, S.; Chud´ık, M.; Mastihuba, V.; Decroix, B. Heterocycles
1998, 48, 1943. (c) Vo, D.; Matowe, W. C.; Ramesh, M.; Iqbal, N.;
Wolowyk, M. W.; Howlett, S. E.; Knaus, E. E. J. Med. Chem. 1995, 38,
2851. (d) Goldmann, S.; Stoltefuss, J. Angew. Chem., Int. Ed. Engl. 1991,
30, 1559.
(8) Sobolev, A.; Franssen, M. C. R.; Makarova, N.; Duburs, G.; de Groot,
A. Tetrahedron: Asymmetry 2000, 11, 4559 and references cited therein.
(15) Mangeney, P.; Gosmini, R.; Raussou, S.; Commerc¸on, M.; Alexakis,
A. J. Org. Chem. 1994, 59, 1877.
ˇ
(9) By formation of diastereoisomeric salts: (a) Marchal´ın, S.; Cvopova´,
(16) (a) Evans, C. G.; Gestwicki, J. E. Org. Lett. 2009, 11, 2957. (b)
Franke, P. T.; Johansen, R. L.; Bertelsen, S.; Jørgensen, K. A. Chem. Asian
J. 2008, 3, 216. (c) Jiang, J.; Yu, J.; Sun, X.-X.; Rao, Q.-Q.; Gong, L.-Z.
Angew. Chem., Int. Ed. 2008, 47, 2458.
K.; Krizˇ, M.; Baran, P.; Oulyadi, H.; Da¨ıch, A. J. Org. Chem. 2004, 69, 4227
and the references cited therein. (b) Ashworth, I.; Hopes, P.; Levine, D.;
Patel, I.; Salloo, R. Tetrahedron Lett. 2002, 43, 4931. (c) Kosugi, Y.; Hori,
M.; Tatsuo, N. Heterocycles 1994, 39, 591. (d) Arrowsmiths, J. E.;
Campbell, S. F.; Cross, P. E.; Stubbs, J. K.; Burges, R. A.; Gardiner, D. G.;
Blackburn, K. J. J. Med. Chem. 1986, 29, 1696 By chiral HPLC separation:
(e) Kleidernigg, O. P.; Kappe, C. O. Tetrahedron: Asymmetry 1997, 7, 2057.
(10) (a) Ducatti, D. R. B.; Massi, A.; Noseda, M. D.; Duarte, M. E. R.;
Dondoni, A. Org. Biomol. Chem. 2009, 7, 1980. (b) Dondoni, A.; Massi,
A.; Minghini, E.; Bertolasi, V. HelV. Chim. Acta 2002, 85, 3331. (c)
Dondoni, A.; Massi, A.; Minghini, E. Synlett 2002, 89.
(17) For recent reviews about the use of chiral sulfoxides in asymmetric
synthesis, see: (a) Pellisier, H. Tetrahedron 2006, 62, 5559. (b) Ferna´ndez,
I.; Khiar, N. Chem. ReV. 2003, 103, 3651.
(18) (a) Binns, M. R.; Haynes, R. K.; Katsifis, A. G.; Schober, P. A.;
Vonwiller, S. C. J. Am. Chem. Soc. 1988, 110, 5411. (b) Hua, D. H.;
Venkataraman, S.; Coulter, M. J.; Sinai, G. Z. J. Org. Chem. 1987, 52,
719.
(19) (a) Hua, D. H.; Sinai, G. Z.; Venkataraman, S. J. Am. Chem. Soc.
1985, 107, 4088. (b) Hua, D. H. J. Am. Chem. Soc. 1986, 108, 3835. (c)
Hua, D. H.; Venkataraman, S.; Ostrander, R. A.; Sinai, G. Z.; McCann,
P. J.; Coulter, M. J.; Xu, M. R. J. Org. Chem. 1988, 53, 507. (d) Zeng, Z.;
Xu, X. Tetrahedron Lett. 2000, 41, 3459. (e) Jones, D. N.; Maybury,
M. W. J.; Swallow, S.; Tomkinson, N. C. O.; Wood, W. W. Tetrahedron
Lett. 2001, 42, 2193.
(11) (a) Rose, U.; Dra¨ger, M. J. Med. Chem. 1992, 35, 2238. (b) Enders,
D.; Mu¨ller, S.; Demir, A. S. Tetrahedron Lett. 1988, 29, 6437.
(12) (a) Dondoni, A.; Massi, A.; Minghini, E.; Bertolasi, V. Tetrahedron
2004, 60, 2311. (b) Dondoni, A.; Massi, A.; Minghini, E.; Sabbatini, S.;
Bertolasi, V. J. Org. Chem. 2003, 68, 6172.
(13) (a) Imanishi, T.; Miyashita, K.; Nishimoto, M.; Murafuji, H.;
Obikka, S. Chem. Pharm. Bull. 1996, 44, 457. (b) Imanishi, T.; Miyashita,
K.; Nishimoto, M.; Murafuji, H.; Obikka, S. Chem. Pharm. Bull. 1995, 43,
711. (c) Davis, R.; Kern, J. R.; Kurz, L. J.; Pfister, J. R. J. Am. Chem. Soc.
1988, 110, 7873.
(20) For a recent review, see: Fustero, S.; Sanz-Cervera, J. F.; Acen˜a,
J. L.; Sa´nchez-Rosello´, M. Synlett 2009, 525.
(21) Despite the relevance of fluorine in medicinal chemistry, only a few
examples of fluorinated DHPs have been reported. In most of them, fluorine
atoms are present as substituents in the aromatic rings of 4-aryl-1,4-DHPs.
(22) The conjugate addition of carbon nucleophiles over R,ꢀ-unsaturated
sulfoxides has been extensively used in its intermolecular version, while
examples of its intramolecular counterpart are very scarce. See reference 18a.
(14) (a) Cheng, Y. C.; Chen, J. Y.; Lee, M. J. Heterocycles 1996, 43,
2425. (b) Meyers, A. I.; Oppenlaender, T. J. Am. Chem. Soc. 1986, 108,
1989. (c) Meyers, A. I.; Oppenlaender, T. J. Chem. Soc., Chem. Commun.
1986, 920.
Org. Lett., Vol. 12, No. 15, 2010
3485